Infectious Diseases In Animals Research Articles

Mesoporous architectural magnetic halloysite-polymer beads for removing toxic streptomycin from water: A sustainable remediation approach

Streptomycin (STR) is a widely used antibiotic to treat various infectious diseases in humans and animals. Increased STR production and distribution result in harmful residue in soil and water. Consequently, STR exists in biotic- and abiotic-counterpart of the environment and poses potential toxicity and risk due to its bioaccumulation and biomagnification properties. Sustainable remediation of STR from wastewater requires selective, minimal, low-cost, regenerable, and reusable materials as adsorbents. In this study, magnetic-halloysite incorporated polymer composite beads (SPHM) were synthesized and used for the efficient clean-up of toxic STR from wastewater. SPHM has a mesoporous structure with an abundance of oxygen-containing functional groups and exhibits a synergistic STR clean up performance (qm = 235.71 ± 13.98 mg/g). Sorption and interfacial studies revealed that diffusion, hydrophobic and ionic interactions, including electrostatic interaction, are involved in STR remediation. Electrostatic interaction plays a vital role alongside the physical sorption mechanism due to the presence of hydroxyl and carboxyl groups induced from poly (vinyl alcohol) and sodium alginate. Moreover, X-ray photoelectron spectroscopy (XPS) and Time-of-flight secondary ion mass spectrometry (ToF-SIMS) analyses confirm the involvement of opposing charged groups of SPHM and STR in adsorption. SPHM can be magnetically separated in just 20 s and is regenerable and reusable up to 10 times, with outstanding performance and stability. The sorption process requires only a minimal amount of SPHM, i.e., 0.5 g/L for STR clean-up. Even the natural surface water composition did not affect its performance. Hence, natural nanoclay-based, biocompatible and low-cost SPHM has a great potential for the sustainable remediation of streptomycin and other similar antibiotics from wastewater.

Spatiotemporal pattern and suitable areas analysis of equine influenza in global scale (2005-2022).

Equine influenza (EI) is a severe infectious disease that causes huge economic losses to the horse industry. Spatial epidemiology technology can explore the spatiotemporal distribution characteristics and occurrence risks of infectious diseases, it has played an important role in the prevention and control of major infectious diseases in humans and animals. For the first time, this study conducted a systematic analysis of the spatiotemporal distribution of EI using SaTScan software and investigated the important environmental variables and suitable areas for EI occurrence using the Maxent model. A total of 517 occurrences of EI from 2005 to 2022 were evaluated, and 14 significant spatiotemporal clusters were identified. Furthermore, a Maxent model was successfully established with high prediction accuracy (AUC = 0.920 ± 0.008). The results indicated that annual average ultraviolet radiation, horse density, and precipitation of the coldest quarter were the three most important environmental variables affecting EI occurrence. The suitable areas for EI occurrence are widely distributed across all continents, especially in Asia (India, Mongolia, and China) and the Americas (Brazil, Uruguay, USA, and Mexico). In the future, these suitable areas will expand and move eastward. The largest expansion is predicted under SSP126 scenarios, while the opposite trend will be observed under SSP585 scenarios. This study presents the spatial epidemiological characteristics of EI for the first time. The results could provide valuable scientific insights that can effectively inform prevention and control strategies in regions at risk of EI worldwide.

Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea.

We investigated trends in notifiable infectious diseases in both humans and animals during the COVID-19 pandemic in South Korea and compared those data against expected trends had nonpharmaceutical interventions (NPIs) not been implemented. We found that human respiratory infectious diseases other than COVID-19 decreased by an average of 54.7% after NPIs were introduced. On the basis of that trend, we estimated that annual medical expenses associated with respiratory infections other than COVID-19 also decreased by 3.8% in 2020 and 18.9% in 2021. However, human gastrointestinal infectious diseases and livestock diseases exhibited similar or even higher incidence rates after NPIs were instituted. Our investigation revealed that the preventive effect of NPIs varied among diseases and that NPIs might have had limited effectiveness in reducing the spread of certain types of infectious diseases. These findings suggest the need for future, novel public health interventions to compensate for such limitations.

Polyphenolic content, phytochemical profile composition, and bioactive properties of Castilla Rose (Purshia plicata)

One of the greatest risks to human and animal health are infectious diseases caused by pathogenic bacteria, as these microorganisms develop mechanisms of resistance to antimicrobials, as a consequence of the indiscriminate and prolonged use of antimicrobials. This makes the treatment of infectious diseases increasingly difficult, in addition to an increase in treatment costs. These disadvantages have led to the search for alternative therapies based on bioactive compounds such as tannins, and flavonoids. Thus, some plant-derived compounds have been used to counteract infectious diseases and other health disorders. This study aimed to identify polyphenols of purified extract from Purshia plicata, and evaluate the antioxidant potential and the response of in vitro antibacterial activity against pathogen microorganisms of clinical importance for humans and animals. An aqueous extraction was performed and the compounds were purified using liquid chromatography. The total polyphenolic content was measured employing the Folin Ciocalteu and butanol-HCI methods. The polyphenolic profile was identified by HPLC/ESI/MS. These compounds were screened for in vitro antibacterial activity using the agar diffusion method and antioxidant activity was determined by ABTS•+, DPPH•, and FRAP methods. The compounds showed effectiveness against Klebsiella sp, Escherichia coli, and Salmonella sp, and moderate inhibition against Staphylococcus aureus. The total hydrolyzable polyphenols content was 45.7 mg g-1; the total condensed polyphenols content was 27 mg g-1. The results of the antioxidant activity showed that IC50 was reached at 150 µgml-1, 250 µgml-1, and 150 µgml-1. Twelve compounds were identified by HPCL/ESI/MS, the most important being anthocyanins and ellagitannins. The polyphenolic compounds of P. plicata have the potential to be used as pharmacological products with antibacterial and antioxidant properties for the treatment of infectious diseases in animals and humans.

Identification of a New Domestic Pig Cell Line for Growth of African Swine Fever Viruses for Vaccine Production in Uganda.

In this study, a basis for the feasibility of a successful ASF vaccine design program using live attenuated vaccines was sought. One of the challenges to African swine fever (ASF) vaccine development is having a cell line that will provide commercial utility for vaccine production. We set out to address this problem by innovatively identifying possible cell lines from local domestic pigs in the country. Eight tissue types from ASF-negative animals were identified for incorporation into cell line development. These were degraded, incubated, and monitored for cell growth. One cell line, the SIR2-P, grew consistently and confluently and was tested for the ability to grow and isolate field ASF viruses. We report the isolation of ASF viruses in our laboratory for the first time. The P9C virus from Namayingo district exhibited the largest plaque sizes compared to the SQ517B virus from Mukono. The innovative identification of the SIR2-P cell line is proof of concept that newer speciesspecific cell lines can be developed in the Infectious Animal Disease Laboratory (IADL), and utilized to study other animal viruses like Porcine Reproductive and Respiratory Syndrome (PRRS) virus, Foot and mouth disease (FMD) virus, and Swine Influenza. Such cells can be used in vaccine production for other endemic diseases in Uganda. The SIR2-P cell line is currently at passage 65.

Evaluating the mosquito vector range for two orthobunyaviruses: Oya virus and Ebinur Lake virus

BackgroundMosquito-borne viruses cause various infectious diseases in humans and animals. Oya virus (OYAV) and Ebinur Lake virus (EBIV), belonging to the genus Orthobunyavirus within the family Peribunyaviridae, are recognized as neglected viruses with the potential to pose threats to animal or public health. The evaluation of vector competence is essential for predicting the arbovirus transmission risk.MethodsTo investigate the range of mosquito vectors for OYAV (strain SZC50) and EBIV (strain Cu20-XJ), the susceptibility of four mosquito species (Culex pipiens pallens, Cx. quinquefasciatus, Aedes albopictus, and Ae. aegypti) was measured through artificial oral infection. Then, mosquito species with a high infection rate (IR) were chosen to further evaluate the dissemination rate (DR), transmission rate (TR), and transmission efficiency. The viral RNA in each mosquito sample was determined by RT-qPCR.ResultsThe results revealed that for OYAV, Cx. pipiens pallens had the highest IR (up to 40.0%) among the four species, but the DR and TR were 4.8% and 0.0%, respectively. For EBIV, Cx. pipiens pallens and Cx. quinquefasciatus had higher IR compared to Ae. albopictus (1.7%). However, the EBIV RNA and infectious virus were detected in Cx. pipiens pallens, with a TR of up to 15.4% and a transmission efficiency of 3.3%.ConclusionsThe findings indicate that Cx. pipiens pallens was susceptible to OYAV but had an extremely low risk of transmitting the virus. Culex pipiens pallens and Cx. quinquefasciatus were susceptible to EBIV, and Cx. pipiens pallens had a higher transmission risk to EBIV than Cx. quinquefasciatus.Graphical

IMPROVING MCCP VACCINE IN SHEEP: NOVEL STRATEGIES FOR DEVELOPMENT, EFFICACY AND CROSS-PROTECTION

Vaccination serves as a straightforward and efficient method for preventing numerous infectious diseases in animals. One such disease is contagious caprine pleuropneumonia (CCPP), a severe lung ailment affecting small ruminants. This research aimed to create a vaccine utilizing Mycoplasma capricolum subsp. capripneumoniae (Mccp) isolated from KPK, Pakistan. The local Mccp strain was rendered inactive alongside saponin, a substance, to produce the vaccine. The viable count of Mycoplasma mycoides subsp. capripneumoniae (Mccp) was determined to be 1x108 CFU/mL from the stock culture, with an estimated protein content of 0.2g/ml. The developed vaccine underwent testing and comparison with a standard CCPP vaccine in sheep to assess safety and efficacy. Twelve experimental sheep were divided into three groups: A, B, and C. Group A received the new vaccine, group B received the standard vaccine, and group C acted as the control. Groups A and B were further split into two subsets: one remained healthy while the other fell ill. The sheep were closely monitored for any changes over a 75-day post-vaccination period. Blood samples were analyzed for antibodies, showing average antibody GMT titers of 24.3, 84.4, and 128 on days 21, 28, and 35 post-immunization. By day 35, sheep vaccinated with the new vaccine displayed the highest antibody levels. The quadratic relationship (R2) indicated that both saponized and lyophilized vaccines were influenced by the number of days by 57.4% and 55%, respectively. The new vaccine demonstrated superior efficacy in sheep compared to the standard vaccine, with saponin playing a role in its effectiveness. The study successfully deactivated Mycoplasma mycoides subsp. capripneumoniae cells with autoclaved saponin, ensuring a sterile vaccine. In vivo testing in rabbits confirmed the vaccine's safety, while serum analysis in sheep revealed protective antibody responses, with the saponized vaccine eliciting higher titers than the lyophilized version. These findings suggest the potential efficacy of the saponized vaccine against Mccp infection

Viral RNA capping: Mechanisms and antiviral therapy.

RNA capping is an essential trigger for protein translation in eukaryotic cells. Many viruses have evolved various strategies for initiating the translation of viral genes and generating progeny virions in infected cells via synthesizing cap structure or stealing the RNA cap from nascent host messenger ribonucleotide acid(mRNA). In addition to protein translation, a new understanding of the role of the RNA cap in antiviral innate immunity has advanced the field of mRNA synthesis in vitro and therapeutic applications. Recent studies on these viral RNA capping systems have revealed startlingly diverse ways and molecular machinery. A comprehensive understanding of how viruses accomplish the RNA capping in infected cells is pivotal for designing effective broad-spectrum antiviral therapies. Here we systematically review the contemporary insights into the RNA-capping mechanisms employed by viruses causing human and animal infectious diseases, while also highlighting its impact on host antiviral innate immune response. The therapeutic applications of targeting RNA capping against viral infections and the development of RNA-capping inhibitors are also summarized.

FADD promotes type I interferon production to suppress porcine reproductive and respiratory syndrome virus infection.

Porcine reproductive and respiratory syndrome (PRRS) is an epidemic animal infectious disease worldwide, causing huge economic losses to the global swine industry. Fas-associated death domain (FADD) was previously reported to be an adaptor protein that functions in transferring the apoptotic signals regulated by the death receptors. In the current study, we unravel its unidentified role in promoting type I interferon (IFN) production during PRRS virus (PRRSV) infection. We identified that FADD inhibited PRRSV infection via promotion of type I IFN transcription. Overexpression of FADD suppressed the replication of PRRSV, while knockout of FADD increased viral titer and nucleocapsid protein expression. Mechanistically, FADD promoted mitochondrial antiviral signaling protein (MAVS)-mediated production of IFN-β and some IFN-stimulated genes (ISGs). Furthermore, FADD exerted anti-PRRSV effects in a MAVS-dependent manner and increased the type I IFN signaling during PRRSV infection. This study highlights the importance of FADD in PRRSV replication, which may have implications for the future control of PRRS.

Preventing Zoonotic Diseases: An Investigation into Veterinary Medicine's Role in Public Health

Animal infectious diseases are an important public health issue that threatens human health, and veterinarians play an important role in preventing and controlling animal infectious diseases. This study aims to explore the role of veterinarians in preventing animal infectious diseases and public health. Through interviews and questionnaire surveys with veterinary workers, this study collected their practical experience in animal disease monitoring, diagnosis, prevention, and control, as well as their participation and challenges in public health. The research findings reveal the crucial role of veterinarians in the prevention of animal infectious diseases, particularly in improving animal health, maintaining public health safety, and promoting harmonious coexistence between humans and nature. In addition, the study also identified challenges faced by veterinarians in public health work, such as resource constraints, demand for professional knowledge, and insufficient public awareness. Based on the research results, suggestions were proposed to improve the role of veterinarians in public health, in order to provide reference for the future development of veterinarians in the field of public health.

The practice of creating buffer zones in anti-epizootic measures for rabies using the example of the border zone with Finland

One of the important tasks of veterinary medicine in the Russian Federation is the implementation of measures to prevent and eliminate infectious animal diseases[2]. Animal rabies is a zoonotic transboundary disease. It is characterized by natural focality, and wild carnivores, in particular the fox, are considered a reservoir of the rabies pathogen. Since the end of the twentieth century, oral rabies vaccines have been used to prevent rabies in Western Europe and the United States [1,3].This article presents the results of research work in 2003-2009. to create a buffer zone against animal rabies on the border with Finland by oral vaccination of wild carnivores in the Leningrad region, the Republic of Karelia. Live vaccines were used in the work: "FUCHSORAL" (Germany) and domestic ones - "SINRAB" (FGBU "ARRIAH, Vladimir) and its analogue - the vaccine "ORALRABIVAK" produced by OJSC "PZB" (Pokrov).In the Leningrad region and the Republic of Karelia in 2003, the FUCHSORAL vaccine (Germany) was used once, and in subsequent years, double annual vaccination was carried out with domestic vaccines. In Finland, people were constantly vaccinated with the oral rabies vaccine “FUCHSORAL” (Germany), from the “SAD B19” strain [4]We carried out annual 2-fold vaccination (in spring and autumn) of wild carnivores, in accordance with the instructions for use of vaccines, at air temperatures from +2 to +8 C in a zone 50-80 km wide from the border for 6 years. The number of blood serum samples containing a level of rabies virus-neutralizing antibodies sufficient to protect against rabies in the Republic of Karelia increased from 0% to 80%, and in the Leningrad region. from 0% to 70%.As a result of the implementation of planned work in the period 2003-2009. to prevent rabies among wild carnivores in the Leningrad region and the Republic of Karelia, epizootic freedom from rabies was achieved, satisfying the neighboring country.

Animal health emergencies: a gender-based analysis for planning and policy.

There has been increasing recognition of gender-based inequity as a barrier to successful policy implementation. This consensus, coupled with an increasing frequency of emergencies in human and animal populations, including infectious disease events, has prompted policy makers to re-evaluate gender-sensitivity in emergency management planning. Seeking to identify key publications relating to gendered impacts and considerations across diverse stakeholders in different types of animal health emergencies, we conducted a non-exhaustive, targeted scoping review. We developed a matrix for both academic and policy literature that separated animal health emergencies into two major categories: humanitarian crises and infectious disease events. We then conducted semi-structured interviews with key animal health experts. We found minimal evidence of explicit gender responsive planning in animal health emergencies, whether humanitarian or infectious disease events. This was particularly salient in Global North literature and policy planning documents. Although there are some references to gender in policy documents pertaining to endemic outbreaks of African swine fever (ASF) in Uganda, most research remains gender blind. Despite this, implicit gendered themes emerged from the literature review and interviews as being direct or indirect considerations of some research, policy, and implementation efforts: representation; gendered exposure risks; economic impact; and unpaid care. Absent from both the literature and our conversations with experts were considerations of mental health, gender-based violence, and intersectional impacts. To remedy the gaps in gender-based considerations, we argue that the intentional inclusion of a gender transformative lens in animal health emergency planning is essential. This can be done in the following ways: (1) collection of disaggregated data (race, gender, sexual orientation, etc.); (2) inclusion of gender experts; and (3) inclusion of primary gendered impacts (minimal representation of women in policy positions, gender roles, economic and nutrition impacts) and secondary gendered impacts (gender-based violence, mental health, additional unpaid care responsibilities) in future planning.

A Single Electrochemical Biosensor Designed to Detect Any Virus.

Viruses are the primary cause of many infectious diseases in both humans and animals. Various testing methods require an amplification step of the viral RNA sample before detection, with quantitative reverse transcription polymerase chain reaction (RT-qPCR) being one of the most widely used along with lesser-known methods like Nucleic Acid Sequence-Based Amplification (NASBA). NASBA offers several advantages, such as isothermal amplification and high selectivity for specific sequences, making it an attractive option for low-income facilities. In this research, we employed a single electrochemical biosensor (E-Biosensor) designed for potentially detecting any virus by modifying the NASBA protocol. In this modified protocol, a reverse primer is designed with an additional 22-nucleotide sequence (tag region) at the 5'-end, which is added to the NASBA process. This tag region becomes part of the final amplicon generated by NASBA. It can hybridize with a single specific E-Biosensor probe set, enabling subsequent virus detection. Using this approach, we successfully detected three different viruses with a single E-Biosensor design, demonstrating the platform's potential for virus detection.

Evaluation of vector susceptibility in Aedes aegypti and Culex pipiens pallens to Tibet orbivirus.

Mosquito-borne viruses cause various infectious diseases in humans and animals. Tibet orbivirus (TIBOV), a newly identified arbovirus, efficiently replicates in different types of vertebrate and mosquito cells, with its neutralizing antibodies detected in cattle and goats. However, despite being isolated from Culicoides midges, Anopheles, and Culex mosquitoes, there has been a notable absence of systematic studies on its vector competence. Thus, in this study, Aedes aegypti and Culex pipiens pallens were reared in the laboratory to measure vector susceptibility through blood-feeding infection. Furthermore, RNA sequencing was used to examine the overall alterations in the Ae. aegypti transcriptome following TIBOV infection. The results revealed that Ae. aegypti exhibited a high susceptibility to TIBOV compared to Cx. p. pallens. Effective replication of the virus in Ae. aegypti midguts occurred when the blood-feeding titer of TIBOV exceeded 105 plaque-forming units mL-1. Nevertheless, only a few TIBOV RNA-positive samples were detected in the saliva of Ae. aegypti and Cx. p. pallens, suggesting that these mosquito species may not be the primary vectors for TIBOV. Moreover, at 2 dpi of TIBOV, numerous antimicrobial peptides downstream of the Toll and Imd signaling pathways were significantly downregulated in Ae. aegypti, indicating that TIBOV suppressed mosquitos' defense to survive in the vector at an early stage. Subsequently, the stress-activated protein kinase JNK, a crucial component of the MAPK signaling pathway, exhibited significant upregulation. Certain genes were also enriched in the MAPK signaling pathway in TIBOV-infected Ae. aegypti at 7 dpi.IMPORTANCETibet orbivirus (TIBOV) is an understudied arbovirus of the genus Orbivirus. Our study is the first-ever attempt to assess the vector susceptibility of this virus in two important mosquito vectors, Aedes aegypti and Culex pipiens pallens. Additionally, we present transcriptome data detailing the interaction between TIBOV and the immune system of Ae. aegypti, which expands the knowledge about orbivirus infection and its interaction with mosquitoes.

Bacteriophage Therapy in Companion and Farm Animals.

Bacteriophages, which are viruses with restricted tropism for bacteria, have been employed for over a century as antimicrobial agents; they have been largely abandoned in Western countries but are constantly used in Eastern European countries with the advent of antibiotics. In recent decades, the growing spread of multidrug-resistant bacteria, which pose a serious threat to worldwide public health, imposed an urgent demand for alternative therapeutic approaches to antibiotics in animal and human fields. Based on this requirement, numerous studies have been published on developing and testing bacteriophage-based therapy. Overall, the literature largely supports the potential of this perspective but also highlights the need for additional research as the current standards are inadequate to receive approval from regulatory authorities. This review aims to update and critically revise the current knowledge on the application of bacteriophages to treat bacterial-derived infectious diseases in animals in order to provide topical perspectives and innovative advances.

An optimized culture system for efficient derivation of porcine expanded potential stem cells from preimplantation embryos and by reprogramming somatic cells.

Pigs share anatomical and physiological traits with humans and can serve as a large-animal model for translational medicine. Bona fide porcine pluripotent stem cells (PSCs) could facilitate testing cell and drug therapies. Agriculture and biotechnology may benefit from the ability to produce immune cells for studying animal infectious diseases and to readily edit the porcine genome in stem cells. Isolating porcine PSCs from preimplantation embryos has been intensively attempted over the past decades. We previously reported the derivation of expanded potential stem cells (EPSCs) from preimplantation embryos and by reprogramming somatic cells of multiple mammalian species, including pigs. Porcine EPSCs (pEPSCs) self-renew indefinitely, differentiate into embryonic and extra-embryonic lineages, and permit precision genome editing. Here we present a highly reproducible experimental procedure and data of an optimized and robust porcine EPSC culture system and its use in deriving new pEPSC lines from preimplantation embryos and reprogrammed somatic cells. No particular expertise is required for the protocols, which take ~4-6 weeks to complete. Importantly, we successfully established pEPSC lines from both in vitro fertilized and somatic cell nuclear transfer-derived embryos. These new pEPSC lines proliferated robustly over long-term passaging and were amenable to both simple indels and precision genome editing, with up to 100% targeting efficiency. The pEPSCs differentiated into embryonic cell lineages in vitro and teratomas in vivo, and into porcine trophoblast stem cells in human trophoblast stem cell medium. We show here that pEPSCs have unique epigenetic features, particularly H3K27me3 levels substantially lower than fibroblasts.

Scientific justification of Mycobacterium avium survival in natural environment of Republic of Dagestan

Contamination of the environment with the infectious animal disease agents is still a pressing problem for the poultry farms. Mycobacterium avium can grow and replicate in organic wastes from the poultry farms for a long time thus contaminating vast adjacent areas and being the source of infection not only for wild and domestic animals but also for humans. The studies were aimed at the examination of the duration of Mycobacterium avium survival in the natural environment in two geographical regions of the Republic of Dagestan characterized by different soil and climate. Samples of Mycobacterium avium-contaminated feces and soil collected from pastures and farmyards (on the surface and from 5 cm depth) were tested. The experiments demonstrated that pathogenic for chickens mycobacteria survived for up to 30 days in the samples collected in the sub-mountainous areas in summertime, when the air temperature ranged from 15.1 to 30 °С, land surface temperature – from 17 to 38 °С, air humidity – from 44 to 94% and average monthly precipitation amounted to 1.5 mm. From September to May, with the air temperature ranging from –10.8 to +25 °C, land surface temperature from –14 to +30 °C, air humidity 26–100% and average precipitation 0.39 mm, the bacteria survived for up to 213 days on the soil surface on the pastures and farmyards, and for up to 243 days at the depth of 5 cm and in the feces. In the plain area, in the same time period in the slightly saline soil with high humus content and at air temperature from –11.9 to +27.3 °C, soil temperature from –13 to +45 °C, air humidity from 37 to 100% and average precipitation 20.4 mm, Mycobacterium avium survived just like in the sub-mountainous area, i.e. for 213 and 243 days, respectively. The post-mortem lesions in the internal organs of the poultry corresponded to the tuberculosis clinical signs in 86 of 171 birds (50.3%). The study results will allow for the development of the optimal algorithm for animal health and management measures aimed at tuberculosis eradication on the poultry farms.

Evaluation of a Combined Live Attenuated Vaccine against Lumpy Skin Disease, Contagious Bovine Pleuropneumonia and Rift Valley Fever.

The use of effective vaccines is among the most important strategies for the prevention and progressive control of transboundary infectious animal diseases. However, the use of vaccine is often impeded by the cost, a lack of cold chains and other factors. In resource-limited countries in Africa, one approach to improve coverage and reduce cost is to vaccinate against multiple diseases using combined vaccines. Therefore, the objective of this study was to evaluate a combined vaccine for the prevention and control of Lumpy Skin Disease (LSD), Contagious Bovine Pleuropneumonia (CBPP) and Rift Valley fever (RVF). The LSD and CBPP were formulated as a combined vaccine, and the RVF was formulated separately as live attenuated vaccines. These consisted of a Mycoplasma MmmSC T1/44 strain that was propagated in Hayflick-modified medium, RVF virus vaccine, C13T strain prepared in African green monkey cells (Vero), and the LSDV Neethling vaccine strain prepared in primary testis cells. The vaccines were tested for safety via the subcutaneous route in both young calves and pregnant heifers with no side effect, abortion or teratogenicity. The vaccination of calves induced seroconversions for all three vaccines starting from day 7 post-vaccination (PV), with rates of 50% for LSD, 70% for CBPP and 100% for RVF, or rates similar to those obtained with monovalent vaccines. The challenge of cattle vaccinated with the LSD/CBPP and the RVF vaccine afforded full protection against virulent strains of LSDV and RVFV. A satisfactory level of protection against a CBPP challenge was observed, with 50% of protection at 6 months and 81% at 13 months PV. A mass vaccination trial was performed in four regions of Burkina Faso that confirmed safety and specific antibody responses induced by the vaccines. The multivalent LSD/CBPP+RVF vaccine provides a novel and beneficial approach to the control of the three diseases through one intervention and, therefore, reduces the cost and improves vaccination coverage.

Effect of institutional antimicrobial stewardship guidelines on prescription of critically important antimicrobials for dogs and cats.

Veterinary hospital antimicrobial stewardship (AMS) guidelines might help combat antimicrobial resistance (AMR). Determine the conditions and types of infection for which antimicrobial drugs (AMDs) deemed critically important (CIA) by the World Health Organization (WHO) were prescribed and assess the effect of hospital AMS guidelines on adherence to International Society for Companion Animal Infectious Diseases published guidelines for the treatment of superficial bacterial folliculitis, respiratory tract disease and urinary tract infection in these cases. Dogs and cats managed at an academic veterinary hospital from 1/21 to 6/21 and 9/21 to 6/22. Prescriptions of cephalosporins (third or fourth generation), glycopeptides, macrolides/ketolides, polymyxins, and quinolones were identified. Data on culture and susceptibility (C/S) testing and previous AMD exposure were collected. Frequencies were compared between time periods using Fisher's exact test with Bonferroni corrections. In animals prescribed ≥1 WHO-CIA AMD, fluoroquinolones were the most frequently prescribed WHO-CIA class in dogs (567/1724, 32.9%) and cats (192/450, 42.7%). No animals were prescribed carbapenems, dihydrofolate reductase inhibitors/sulfonamides, or polymyxins. No cats were prescribed aminoglycosides or amphenicols. Institutional guidelines were followed in 57.8% (324/561) cases. The most frequent causes of nonadherence were failure to perform C/S testing 46.0% (109/237) and unnecessary use of a higher-tier AMD 43.0% (102/237). Bacterial C/S testing was more frequently performed after AMS guideline institution (59.7% vs. 46.8%, P = 0.0006). Adherence to published guidelines remained poor despite an increase in C/S testing. There were no changes in the frequencies of confirmed infections, positive cultures or AMD resistance between time periods.

Development of a time-resolved fluorescence immunoassay kit for detecting canine coronavirus and parvovirus through double labeling

ObjectiveCanine enteric coronavirus (CCV) and canine parvovirus type 2 (CPV-2) are the main pathogens responsible for acute gastroenteritis in dogs, and both single and mixed infections are common. This study aimed to establish a double-labeling time-resolved fluorescence immunoassay (TRFIA) to test and distinguish CCV and CPV-2 diseases.MethodsA sandwich double-labeling TRFIA method was established and optimized using europium(III) (Eu3+)/samarium(III) (Sm3+) chelates. CCV/CPV-2 antigens were first captured by the immobilized antibodies. Then, combined with Eu3+/Sm3+-labeled paired antibodies, the Eu3+/Sm3+ fluorescence values were detected after dissociation to calculate the CCV/CPV-2 ratios. The performance, clinical performance and methodology used for laboratory (sensitivity, specificity, accuracy and stability) testing were evaluated.ResultsA double-label TRFIA for CCV and CPV-2 detection was optimized and established. The sensitivity of this TRFIA kit was 0.51 ng/mL for CCV and 0.80 ng/mL for CPV-2, with high specificity for CCV and CPV-2. All the accuracy data were less than 10%, and the recovery ranged from 101.21 to 110.28%. The kits can be temporarily stored for 20 days at 4 °C and can be stored for 12 months at temperatures less than − 20 °C. Based on a methodology comparison of 137 clinically suspected patients, there was no statistically significant difference between the TRFIA kit and the PCR method. Additionally, for CCV detection, the clinical sensitivity was 95.74%, and the clinical specificity was 93.33%. For CPV-2 detection, the clinical sensitivity was 92.86%, and the clinical specificity was 96.97%.ConclusionIn this study, a double-label TRFIA kit was prepared for CCV and CPV-2 detection with high laboratory sensitivity, specificity, accuracy, stability, clinical sensitivity and specificity. This kit provides a new option for screening/distinguishing between CCV and CPV-2 and may help improve strategies to prevent and control animal infectious diseases in the future.